MyLeukemiaTeam

Yes, joint pain is a reported side effect of Gleevec (imatinib), which is used to treat chronic myeloid leukemia (CML). Many people with leukemia, including those taking Gleevec, have shared their experiences with joint pain. Some have mentioned that the pain can be severe enough to make walking difficult. Here are some Show Full Answer

Yes, joint pain is a reported side effect of Gleevec (imatinib), which is used to treat chronic myeloid leukemia (CML). Many people with leukemia, including those taking Gleevec, have shared their experiences with joint pain. Some have mentioned that the pain can be severe enough to make walking difficult. Here are some relevant points:

- Joint Pain: Gleevec can cause pain in muscles and bones, which may include joint pain.
- Impact on Mobility: Several members have reported that their pain is severe enough to affect their ability to walk.
- Management: Adjustments like using cushioned shoes or inner sole padding can help alleviate foot pain, which might also benefit joint pain.

For more detailed personal experiences, you might find it helpful to connect with others on platforms like MyLeukemiaTeam.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

Is Leukemia Painful? Common Areas of Pain and Management | MyLeukemiaTeam

Gleevec (Imatinib) for Leukemia | MyLeukemiaTeam